Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 319-24-4 | MDL No. : | MFCD03791308 |
Formula : | C8H8FNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PUDDYSBKCDKATP-UHFFFAOYSA-N |
M.W : | 169.15 | Pubchem ID : | 2783401 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 42.08 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.37 cm/s |
Log Po/w (iLOGP) : | 1.67 |
Log Po/w (XLOGP3) : | 2.77 |
Log Po/w (WLOGP) : | 1.62 |
Log Po/w (MLOGP) : | 1.75 |
Log Po/w (SILICOS-IT) : | 1.4 |
Consensus Log Po/w : | 1.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.87 |
Solubility : | 0.227 mg/ml ; 0.00134 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.52 |
Solubility : | 0.0506 mg/ml ; 0.000299 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.39 |
Solubility : | 0.692 mg/ml ; 0.00409 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.33 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With hydrogen In methanol for 120 h; | Step 1 : Preparation of 2-Amino-5-fluoro-benzoic acid methyl ester :; To a solution OF 5-FLUORO-2-NITRO-BENZOIC acid methyl ester (24. 8 g, 125 mmol) in CH30H was added 10percent BY WEIGHT PD on activated carbon (2. 58 g) under nitrogenous atmosphere. The vessel was then purged with and stirred under 1 atmosphere H2 for 5 d. FILTRATION THROUGH CELITE and silica gel chromatography eluting with a gradient of 0 to 30percent ethyl acetate in hexanes afforded 19. 7 g (88percent) of the title compound as a yellow OIL. 1H NMR (300 MHz, CDC13) B 7. 53 (dd, J= 3. 1, 9. 7 Hz, 1H), 7. 03 (DDD, J= 3. 1, 7. 8, 9. 0 Hz, 1H), 6. 62 (dd, J= 4. 5, 9. 0 Hz, 1H), 5. 57 (br s, 2H), 3. 87 (s, 3H) ; 19F NMR (282 MHz, CDC13) ppm-128. 80 (ddd, J= 4. 9, 8. 0, 9. 7 Hz) ; LC/MS : FA standard Rt = 1. 60 min, EX 170. 07. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | Stage #1: at 100℃; Stage #2: With water; potassium carbonate In dichloromethane |
Intermediate 53; Methyl 2-amino-5-fluorobenzoateA solution of 2-amino-5-fluorobenzoic acid (9.29 mmol, 1.440 g) in a mixture of HCI/MeOH (3N, 30 ml) was heated at 1000C overnight. The solvent was evaporated and the crude mixture was extracted between DCM and K2CO3 saturated aqueous solution. The organic phase was evaporated and the crude mixture was purified by chromatography over SiO2 with hexane/ethyl acetate mixtures affording 0.650 g (yield 42percent) of the expected product. <n="67"/>δ 1H NMR (200 MHz, CDCI3): 3.9 (s, 3H), 5.6 (s, 2H), 6.6 (dd, J=9.0, 4.7 Hz1 1 H), 7.0 (m, 1 H), 7.5 (dd, J=9.8, 3.1 Hz, 1 H). ESI/MS (m/e, percent): 170 [(M+1)\\ 100]. |
[ 2475-81-2 ]
Methyl 2-amino-4-fluorobenzoate
Similarity: 0.97
[ 207346-42-7 ]
Methyl 2-amino-4,5-difluorobenzoate
Similarity: 0.95
[ 144851-82-1 ]
Methyl 2-amino-3-fluorobenzoate
Similarity: 0.95
[ 185629-32-7 ]
Methyl 4-amino-3-fluorobenzoate
Similarity: 0.94
[ 369-26-6 ]
Methyl 3-amino-4-fluorobenzoate
Similarity: 0.92
[ 2475-81-2 ]
Methyl 2-amino-4-fluorobenzoate
Similarity: 0.97
[ 207346-42-7 ]
Methyl 2-amino-4,5-difluorobenzoate
Similarity: 0.95
[ 144851-82-1 ]
Methyl 2-amino-3-fluorobenzoate
Similarity: 0.95
[ 185629-32-7 ]
Methyl 4-amino-3-fluorobenzoate
Similarity: 0.94
[ 369-26-6 ]
Methyl 3-amino-4-fluorobenzoate
Similarity: 0.92
[ 2475-81-2 ]
Methyl 2-amino-4-fluorobenzoate
Similarity: 0.97
[ 207346-42-7 ]
Methyl 2-amino-4,5-difluorobenzoate
Similarity: 0.95
[ 144851-82-1 ]
Methyl 2-amino-3-fluorobenzoate
Similarity: 0.95
[ 185629-32-7 ]
Methyl 4-amino-3-fluorobenzoate
Similarity: 0.94
[ 369-26-6 ]
Methyl 3-amino-4-fluorobenzoate
Similarity: 0.92
[ 2475-81-2 ]
Methyl 2-amino-4-fluorobenzoate
Similarity: 0.97
[ 207346-42-7 ]
Methyl 2-amino-4,5-difluorobenzoate
Similarity: 0.95
[ 144851-82-1 ]
Methyl 2-amino-3-fluorobenzoate
Similarity: 0.95
[ 185629-32-7 ]
Methyl 4-amino-3-fluorobenzoate
Similarity: 0.94
[ 369-26-6 ]
Methyl 3-amino-4-fluorobenzoate
Similarity: 0.92